questionable usefulness of anticoagulants for certain patients

questionable usefulness of anticoagulants for certain patients
questionable usefulness of anticoagulants for certain patients

Currently, doctors routinely prescribe anticoagulants to their patients under the age of 65 who do not have other cardiovascular risk factors in the hope of avoiding future after-effects.

This practice could now change, predicted the author of the study, Dr. Léna Rivard.

“We have an answer, that is to say that there is no point in giving this medication to reduce cognitive decline,” said Dr. Rivard, who is a cardiologist specializing in electrophysiology at the ICM and associate clinical professor. at the Faculty of Medicine of the University of Montreal. The next step is to generate hypotheses to help these patients.”

The BRAIN-AF study was stopped prematurely, as the data generated by Dr. Rivard and her colleagues clearly demonstrated that taking anticoagulants had no impact on the risk of cognitive decline, stroke or transient ischemic attack in these otherwise healthy young patients.

Just under 20% of study participants lost at least two points on the MoCA Cognition Rating Scale during the average follow-up of 3.7 years, consistent with the decline normally seen in a patient over a ten-year follow-up, said Dr. Rivard. “We do not lower our MoCA by two points in four years,” she insisted.

In light of these findings, she added, doctors will now have to try to understand how atrial fibrillation increases the risk of dementia or cognitive decline later in life because they are unable, at this time, to to determine which patients are at risk of being victims.

“It shows us that the link (between AF and cognitive decline) is not via cerebral embolisms, that there is something else,” said Dr. Rivard. The next step is to be able to delimit the population which is at risk of lowering its cognitive test.

To this end, Dr. Rivard is delighted to be able to count on what she calls a “pure population”, namely young subjects without risk factors, unlike previous studies in which we found several participants with heart disease.

For now, she concluded, these young, otherwise healthy patients can simply be advised to follow the usual advice regarding a healthy lifestyle.

The results of this study were revealed a few days ago in Chicago, as part of a congress of the American Heart Association.

-

-

PREV CARDIOVASCULAR RISK: Oculomics, AI and the retina to detect it
NEXT The Châteauguay Sun | Integrated health and social services center of Montérégie-Ouest: artificial intelligence is gradually taking hold